Skip to content
10-Q

Quarterly Report

VICAPSYS LIFE SCIENCES, INC. VICP

0001493152-22-033024

← back to feed
Filed
Nov 21, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 21, 2022 31.92M sh
Current Liabilities Q3 2022 · Sep 30, 2022 $904.08K
Current Liabilities Q3 2022 · Dec 31, 2021 $715.96K
Current Assets Q3 2022 · Sep 30, 2022 $35.75K
Current Assets Q3 2022 · Dec 31, 2021 $222.79K
Total Assets Q3 2022 · Sep 30, 2022 $383.8K
Total Assets Q3 2022 · Dec 31, 2021 $594.31K
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$320.72K
Stockholders Equity Q3 2022 · Sep 30, 2021 −$193.88K
Stockholders Equity Q3 2022 · Jun 30, 2021 −$258.78K
Stockholders Equity Q3 2022 · Mar 31, 2021 −$397.79K
Stockholders Equity Q3 2022 · Dec 31, 2020 −$449.11K
Eps Basic Q3 2022 · Sep 30, 2021 −$0.01
Eps Basic Q3 2022 · Sep 30, 2021 −$0.01
Sga Expense Q3 2022 · Sep 30, 2021 $8.64K
Sga Expense Q3 2022 · Sep 30, 2021 $26.41K
Rd Expense Q3 2022 · Sep 30, 2021 $7.24K
Net Income Q3 2022 · Sep 30, 2021 −$111.18K
Net Income Q3 2022 · Sep 30, 2021 −$133.01K
Net Income Q3 2022 · Jun 30, 2021 −$72.06K
Net Income Q3 2022 · Mar 31, 2021 $50.23K
Operating Income Q3 2022 · Sep 30, 2021 −$111.18K
Operating Income Q3 2022 · Sep 30, 2021 −$233.01K